- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03432182
Body Movements Analysis During Sleep in Very Premature Infants (DODOPREMA)
August 16, 2024 updated by: Jean-Michel HASCOET, Central Hospital, Nancy, France
Characterization of Movements Occurring During Sleep in Very Premature Neonates: Relationship With Neurodevelopmental Outcome
Sleep is a key factor for normal brain development of the newborn.
However, it is poorly studied and little is known about its characterization, especially in premature infants.
Body movements during sleep are easy to evaluate but studies on their relationship to normal sleep states are scarce and limited.
This project aims to characterize body movements during sleep, assessed by electroencephalography, in very premature infants.
Then, a correlation between body movements, sleep organization and neurodevelopmental outcome will be evaluated at 3 years of age.
Study Overview
Study Type
Interventional
Enrollment (Actual)
68
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Nancy, France, 54035
- Maternity Hospital CHRU
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 week to 2 weeks (Child)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Infants born between 26 and 32 weeks gestation
Exclusion Criteria:
- Genetic abnormality
- Neurological pathology such as intraventricular hemorrhage > grade 2
- Any medication know for altering electroencephalography recording
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: very premature infants
Electroencephalography allowing sleep observation
|
Sleep states definition by electroencephalograpy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body movements evaluation during sleep
Time Frame: 3 months
|
number of movements observed according to sleep states
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sleep states organization
Time Frame: 3 months
|
sleep states characterization by electroencephalography according to postmenstrual age
|
3 months
|
|
Type of movements observed during sleep
Time Frame: 3 months
|
Movements characterization according to sleep states
|
3 months
|
|
Neurodevelopmental outcome
Time Frame: 3 years
|
neuropsychomotor evaluation by Bayley psychometric test
|
3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 28, 2018
Primary Completion (Actual)
June 30, 2024
Study Completion (Actual)
August 15, 2024
Study Registration Dates
First Submitted
February 1, 2018
First Submitted That Met QC Criteria
February 7, 2018
First Posted (Actual)
February 14, 2018
Study Record Updates
Last Update Posted (Actual)
August 19, 2024
Last Update Submitted That Met QC Criteria
August 16, 2024
Last Verified
August 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017-A02687-46
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep
-
University of Wisconsin, MadisonPhilips HealthcareCompletedSleep, Slow-wave Sleep, Sleep Enhancement, Sleep Optimization
-
Brain Electrophysiology Laboratory CompanyRecruiting
-
University GhentEuropean CommissionCompleted
-
Mahidol UniversityRamathibodi HospitalNot yet recruitingSleep Inertia | Sleep, Slow-wave Sleep, Sleep Enhancement, Sleep Optimization | Night Shift WorkThailand
-
Northumbria UniversityCompletedSleep | Mood | Poor Quality Sleep | Good Sleep HabitUnited Kingdom
-
Universidade Federal de PernambucoEnrolling by invitationSleep | Obstructive Sleep Apnea (OSA)Brazil
-
Atlas UniversityCompletedSleep | Surgery | Sleep QualityTurkey (Türkiye)
-
Mersin UniversityCompletedSleep Quality | Sleep PerceptionTurkey (Türkiye)
-
Brigham and Women's HospitalNot yet recruitingObstructive Sleep Apnea | Sleep-disordered BreathingUnited States
-
Institute of Nutrition, Slovenia (Nutris)Valens Int. d.o.o., Slovenija; Faculty of Pharmacy, University of Ljubljana... and other collaboratorsNot yet recruitingSleep Quality | Sleep Onset LatencySlovenia
Clinical Trials on electroencephalography
-
Centre Hospitalier Universitaire de BesanconTerminated
-
Daegu Catholic University Medical CenterCompletedAttention Deficit Hyperactivity Disorder | Psychiatric Diagnosis | Diagnosis, PsychiatricKorea, Republic of
-
Rennes University HospitalCompleted
-
University Hospital, CaenCentre Hospitalier Universitaire de BesanconNot yet recruitingNeurodevelopmental Changes (Childhood, Ageing)
-
Assistance Publique Hopitaux De MarseilleRecruiting
-
Parc de Salut MarAelis Farma; StarlabRecruiting
-
Ulrich MehnertNCCR (National Center of Competence in Resaerch, Switzerland)CompletedHealthy | Neurogenic Bladder Dysfunction Nos | Nonneurogenic Neurogenic Bladder DysfunctionSwitzerland
-
Guangzhou Women and Children's Medical CenterBeijing X-Magtech Technology LimitedRecruitingRefractory Epilepsy in ChildrenChina
-
Central Hospital, Nancy, FranceInstitut National de la Santé Et de la Recherche Médicale, France; CHU de Reims and other collaboratorsCompletedPartial EpilepsyFrance
-
Xuanwu Hospital, BeijingNot yet recruitingAnterior Large Vessel Occlusion StrokeChina